WEKO3
アイテム
{"_buckets": {"deposit": "61daa08d-e3da-4724-b197-b79b0e44cf49"}, "_deposit": {"created_by": 1, "id": "69934", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "69934"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00069934", "sets": ["28"]}, "author_link": ["686670", "686674", "686682", "686668", "686678", "686679", "686672", "686675", "686676", "686680", "686677", "686669", "686683", "686681", "686673", "686671"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2009-11-07", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "OBJECTIVE: To determine the effectiveness of carbon ion radiotherapy (CIRT) for localized primary sarcoma of the extremities.\nPATIENTS AND METHODS: From April 2000 to February 2009, 16 (male/female:11/5) patients with localized primary sarcoma of the extremities received CIRT. Age ranged from 14 to 83 years (median 53 years). Nine patients had primary diseases and 7 had recurrent diseases. Of 16 patients, 8 refused amputation, remaining 8 refused surgical resection. Tumors located upper limbs in 4 patients and lower limbs in 12. Histological diagnoses were as follows: malignant fibrous histiocytoma in 4, osteoarcoma in 3, malignant peripheral nerve sheath tumor in 2, synovial sarcoma in 2, and miscellaneous in 5 patients. The CIRT dose to the limb was 52.8 GyE for 1 patient, 64GyE for 4, 70.4GyE for 11 in fixed16 fractions over 4weeks. Records were reviewed and outcomes including radiologic response, local control (progression-free), and survival were analyzed.\nRESULTS: The median follow-up was 25 months (range: 5 to 70 months). Radiological response rate was 56% (PR in 9, SD in 6, PD in 1). The local control rates at 4 years were 75%. The overall survival rates at 4 years were 69%. 12 Of 16 patients were alive without disease progression, 3 patients were died due to systemic disease and remaining one was died due to leukemia 57 months after CIRT. No toxicity greater than Grade 2 was observed.\nCONCLUSION: CIRT is suggested to be an effective and safe treatment for patients who refused surgery with localized primary sarcoma of the extremities.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "15th Annual CTOS Meeting", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Sugahara, Shinji"}], "nameIdentifiers": [{"nameIdentifier": "686668", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "686669", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imai, Reiko"}], "nameIdentifiers": [{"nameIdentifier": "686670", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "686671", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suzuki, Motohisa"}], "nameIdentifiers": [{"nameIdentifier": "686672", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Tohru"}], "nameIdentifiers": [{"nameIdentifier": "686673", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "686674", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tatezaki, Shinichiroh"}], "nameIdentifiers": [{"nameIdentifier": "686675", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "菅原 信二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686676", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686677", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "今井 礼子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686678", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686679", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鈴木 志恒", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686680", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 徹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686681", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686682", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "舘崎 愼一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "686683", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Carbon ion radiotherapy for localized primary sarcoma of the extremities", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon ion radiotherapy for localized primary sarcoma of the extremities"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/69934", "pubdate": {"attribute_name": "公開日", "attribute_value": "2009-11-10"}, "publish_date": "2009-11-10", "publish_status": "0", "recid": "69934", "relation": {}, "relation_version_is_last": true, "title": ["Carbon ion radiotherapy for localized primary sarcoma of the extremities"], "weko_shared_id": -1}
Carbon ion radiotherapy for localized primary sarcoma of the extremities
https://repo.qst.go.jp/records/69934
https://repo.qst.go.jp/records/699343af5a4f2-ab9e-4179-bea1-76fff88bd847
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2009-11-10 | |||||
タイトル | ||||||
タイトル | Carbon ion radiotherapy for localized primary sarcoma of the extremities | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Sugahara, Shinji
× Sugahara, Shinji× Kamada, Tadashi× Imai, Reiko× Tsuji, Hiroshi× Suzuki, Motohisa× Okada, Tohru× Tsujii, Hirohiko× Tatezaki, Shinichiroh× 菅原 信二× 鎌田 正× 今井 礼子× 辻 比呂志× 鈴木 志恒× 岡田 徹× 辻井 博彦× 舘崎 愼一郎 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | OBJECTIVE: To determine the effectiveness of carbon ion radiotherapy (CIRT) for localized primary sarcoma of the extremities. PATIENTS AND METHODS: From April 2000 to February 2009, 16 (male/female:11/5) patients with localized primary sarcoma of the extremities received CIRT. Age ranged from 14 to 83 years (median 53 years). Nine patients had primary diseases and 7 had recurrent diseases. Of 16 patients, 8 refused amputation, remaining 8 refused surgical resection. Tumors located upper limbs in 4 patients and lower limbs in 12. Histological diagnoses were as follows: malignant fibrous histiocytoma in 4, osteoarcoma in 3, malignant peripheral nerve sheath tumor in 2, synovial sarcoma in 2, and miscellaneous in 5 patients. The CIRT dose to the limb was 52.8 GyE for 1 patient, 64GyE for 4, 70.4GyE for 11 in fixed16 fractions over 4weeks. Records were reviewed and outcomes including radiologic response, local control (progression-free), and survival were analyzed. RESULTS: The median follow-up was 25 months (range: 5 to 70 months). Radiological response rate was 56% (PR in 9, SD in 6, PD in 1). The local control rates at 4 years were 75%. The overall survival rates at 4 years were 69%. 12 Of 16 patients were alive without disease progression, 3 patients were died due to systemic disease and remaining one was died due to leukemia 57 months after CIRT. No toxicity greater than Grade 2 was observed. CONCLUSION: CIRT is suggested to be an effective and safe treatment for patients who refused surgery with localized primary sarcoma of the extremities. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 15th Annual CTOS Meeting | |||||
発表年月日 | ||||||
日付 | 2009-11-07 | |||||
日付タイプ | Issued |